A Phase 1, Double-Blind, Randomized, Placebo-Controlled Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-04287881 After Administration Of Multiple Escalating Oral Doses To Healthy Adult Subjects.
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2010
At a glance
- Drugs PF 4287881 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
- 15 Jul 2010 Actual patient number (39) added as reported by ClinicalTrials.gov.
- 15 Jul 2010 Actual end date (Jul 2010) added as reported by ClinicalTrials.gov.
- 15 Jul 2010 Status changed from discontinued to completed as reported by ClinicalTrials.gov.